Neuroinflammation and gut microbiota in AD progression

Add to your list(s) Download to your calendar using vCal

• Nathan Zaccai (University of Cambridge)
• Thursday 21 November 2019, 14:00-15:00
• Sackler Lecture room, Level 7, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, CBC.

If you have a question about this talk, please contact Veronica Kane Dickson.

Nathan Zaccai of the CIMR will be guiding us through the recent research investigating the impact of gut microbiota on neuroinflammation and AD pathogenesis, which has led to approval of oligomannate as a treatment for mild to moderate AD in China.

Wang, X., Sun, G., Feng, T. et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29, 787–803 (2019) doi:10.1038/s41422-019-0216-x https://www.nature.com/articles/s41422-019-0216-x

This talk is part of the Dementia Journal Club series.

This talk is included in these lists:

• Biology
• Cambridge Neuroscience Seminars
• Cambridge talks
• Chris Davis' list
• Dementia Journal Club
• Featured lists
• Life Science
• Life Sciences
• Neuroscience
• Neuroscience Seminars
• Neuroscience Seminars
• Sackler Lecture room, Level 7, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, CBC
• Seminars
• Stem Cells & Regenerative Medicine
• dh539

Note that ex-directory lists are not shown.